Kunkel, Lori A.
Syndax Pharmaceuticals (United States)
2 papers on CoChat
Most cited papers
- Verified
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 1,685
- Verified
ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
Batlevi, C. L., Kasamon, Y., Bociek, R. G., Lee, P., Gore, L., Copeland, A., Sorensen, R., Ordentlich, P., Cruickshank, S., Kunkel, L., et al. (2016) · Haematologica
Lymphoma Diagnosis and TreatmentHistone Deacetylase Inhibitors Research
Cited by 59
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free